FDA NDC Directory · JSON-LD · Markdown

ZYPREXA Zydis

NDC 61269-652 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Generic nameOlanzapine
Labeler / ManufacturerH2-Pharma LLC
Marketing categoryNew Drug Application (innovator) · App NDA021086
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsOLANZAPINE (15 mg/1)
Marketing started20010901
Package count1

External sources

Source: openFDA. Public-domain (CC0).